Australian Dairy Nutritionals Group (AHF) AI Stock Analysis

• Market Cap: AU$28.25M
• Dividend Yield: N/A
• Average Volume (3M): 334.72K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.08
• Revenue Growth: 13.92%
• EPS Growth: 36.28%
• Country: AU
• Employees: N/A
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): >-0.01
• Shares Outstanding: 743,321,840
• 10 Day Avg. Volume: 614,993
• 30 Day Avg. Volume: 334,722
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: AU$0.00 ▼(-100.00% Downside)

The overall stock score is primarily influenced by the company's financial performance challenges, including negative profitability and cash flow issues. Technical analysis indicates a bearish trend, while valuation metrics are unattractive due to negative earnings and lack of dividends. The absence of earnings call data and corporate events means these factors do not impact the score.

Australian Dairy Nutritionals Group Business Overview & Revenue Model

Company Description

Australian Dairy Nutritionals Group (AHF) is a leading player in the Australian dairy industry, specializing in the production and export of high-quality dairy nutritional products. The company operates across several sectors, including infant formula, nutritional powders, and dairy-based ingredients, catering to both domestic and international markets. AHF is committed to sustainability and innovation in dairy farming and product development, ensuring that its offerings meet the highest standards of quality and nutritional value.

How the Company Makes Money

AHF generates revenue primarily through the sale of its dairy nutritional products, including infant formula and nutritional powders, which are sold both domestically and internationally. The company has established significant partnerships with distributors and retailers, enhancing its market reach and driving sales. Key revenue streams include direct sales to consumers, bulk sales to retailers, and exports to overseas markets. Additionally, AHF may benefit from economies of scale in production and supply chain efficiencies, which contribute to its profitability. The company's commitment to quality and innovation also allows it to command premium pricing for its products, further bolstering its revenue.

Australian Dairy Nutritionals Group Financial Statement Overview

Summary

Australian Dairy Nutritionals Group is facing significant financial challenges with declining revenues and persistently negative profitability margins. While the balance sheet shows low leverage, the company's inability to generate positive free cash flow and improve revenue growth is concerning. The company's financial health is under pressure, requiring strategic measures to stabilize operations and enhance financial performance.

Income Statement

The company has been experiencing declining revenues with a sharp drop from 2020 to 2024. The gross profit margin turned positive in 2024, improving from previous negative figures, but the net profit margin remained deeply negative due to persistent net losses. EBIT and EBITDA margins also indicate operational challenges. Revenue growth is negative, highlighting a decreasing trend in sales.

Balance Sheet

The debt-to-equity ratio is relatively low, indicating conservative leverage, but the declining stockholders' equity and increasing net debt over time raise concerns. Return on Equity remains negative due to negative net income, and the equity ratio shows a decreasing trend in stockholders' equity as a percentage of total assets, pointing to weakening balance sheet strength.

Cash Flow

Free cash flow has shown some improvement in 2024 but remains negative, indicating cash outflows. The operating cash flow to net income ratio is not favorable, as both figures are negative. Despite some improvements in investing cash flows, the company struggles with positive free cash flow, reflecting ongoing cash management challenges.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	5.32M	7.17M	6.18M	5.86M	5.80M	21.30M
Gross Profit	-707.05K	-1.42M	-2.15M	-288.23K	-4.36M	-3.27M
EBITDA	-5.97M	-4.30M	-6.26M	-5.95M	-1.29M	-5.34M
Net Income	-6.72M	-5.21M	-7.36M	-9.16M	-4.15M	-6.40M
Balance Sheet
Total Assets	28.44M	25.09M	30.35M	36.24M	44.60M	43.11M
Cash, Cash Equivalents and Short-Term Investments	4.48M	2.69M	6.13M	2.01M	2.43M	6.23M
Total Debt	424.40K	48.45K	2.25M	1.04M	1.09M	6.49M
Total Liabilities	1.63M	1.44M	3.62M	2.72M	4.65M	9.12M
Stockholders Equity	26.95M	23.85M	26.87M	33.59M	16.05M	33.99M
Cash Flow
Free Cash Flow	-4.24M	-3.46M	-4.72M	-7.91M	-6.90M	-7.11M
Operating Cash Flow	-3.97M	-3.28M	-4.44M	-7.05M	-3.80M	-2.03M
Investing Cash Flow	6.74M	-47.59K	6.73M	6.18M	3.10M	1.07M
Financing Cash Flow	1.31M	-94.51K	1.80M	449.98K	-3.07M	796.49K

Australian Dairy Nutritionals Group Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.04
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AHF, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 33.98 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:AHF.

Australian Dairy Nutritionals Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLV	―	AU$108.55M	15.48	10.07%	2.59%	38.25%	361.54%
BUB	―	AU$138.59M	25.00	13.97%	―	28.66%	―
Sector *	―	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BGA	―	€1.64B	―	-0.68%	2.25%	0.49%	-127.84%
AHF	―	AU$28.25M	―	-20.54%	―	13.92%	36.28%
NUC	―	AU$20.23M	5.77	-29.43%	―	102.21%	69.47%
NOU	―	AU$36.02M	―	―	―	1.03%	-52.56%

Australian Dairy Nutritionals Group Corporate Events

Australian Dairy Nutritionals Group Announces Director’s Interest Change

Australian Dairy Nutritionals Group announced a change in the director’s interest, specifically regarding Peter Nathan’s indirect holdings. The change involved the acquisition of 740,000 fully paid ordinary shares through an on-market trade, reflecting a potential strategic move to strengthen the director’s investment in the company.

Australian Dairy Nutritionals Announces 2025 Annual General Meeting

Australian Dairy Nutritionals Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled for October 30, 2025, in Docklands, Victoria. The company encourages shareholders to submit questions in advance and vote via proxy to facilitate efficient communication. This meeting is an opportunity for stakeholders to engage with the company’s leadership and discuss future directions, reflecting AHF’s commitment to transparency and shareholder engagement.

Director’s Interest Change at Australian Dairy Nutritionals

Australian Dairy Nutritionals Group announced a change in the director’s interest, with Peter Nathan acquiring additional shares through indirect holdings. This transaction, conducted via on-market trades, reflects a strategic adjustment in the director’s investment, potentially impacting the company’s shareholder structure and market perception.

Australian Dairy Nutritionals Group Releases Corporate Governance Statement

Australian Dairy Nutritionals Group has released its corporate governance statement for the financial year ending June 30, 2025, which is now available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, highlighting their commitment to transparency and accountability in management and oversight. This move is likely to reinforce stakeholder confidence and enhance the company’s industry positioning by demonstrating robust governance practices.

Australian Dairy Nutritionals Group Reports Revenue Growth and Reduced Losses for FY 2025

Australian Dairy Nutritionals Group reported a 14% increase in revenue from ordinary activities for the year ended June 30, 2025, reaching $7.168 million. Despite the revenue growth, the company experienced a 29% reduction in losses, reporting a loss of $5.261 million after tax. The net tangible asset backing per share decreased from 4.1 cents to 3.2 cents, and no dividends were declared for the period. The financial results indicate a challenging yet improving financial position for the company, with implications for stakeholders regarding future profitability and asset valuation.